Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-08-20
1988-11-01
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
047820772
ABSTRACT:
A method of treating neurological disorders, in particular Parkinson's disease, is disclosed. The method involves administering an aristolactam, especially Taliscanin, an extract of the root of Aristolochia Taliscana, to an afflicted patient. The dosage is varied in accordance with the patient's response, and generally ranges from 300 to 4000 micrograms per day. Taliscanin has also been shown effective in treating Alzheimer disease and impotence.
REFERENCES:
"The Aristolochic Acids and Aristolactams", Journal of Natural Products, vol. 5, No. 5 (1982), by D. B. Mix et al.
"Tumor Inhibitors x. Photochemical Synthesis of Phenanthrenes Synthesis of Aristolochic Acid and Related Compounds", Journal of Organic Chemistry, vol. 30, by S. M. Kupchan and H. C. Warmser.
"The Aristolochic Acids and Aristolactams," Isoquinoline Alkaloid Research, Plenum Press, Chapter 17 (1978), by Channer.
Nervous System, "A Strategic Approach to Parkinson's", Emergency Medicine, 95-11 (Apr. 30, 1987), by J. Fermaglich.
Las Aristoloquias Medicinales, Anales de el Instituto Medico Nacional Mexicod, Mexico D. F., Tomo VIII, 16.
"La Taliscanina, un Componente De Aristolochia Taliscana", Cincia Mexico, vol. 24, by L. Maldanado et al.
Friedman Stanley J.
Mirabel Eric P.
Monoclonetics International, Inc.
LandOfFree
Taliscanin and other aristolactams for treating neurological dis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Taliscanin and other aristolactams for treating neurological dis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taliscanin and other aristolactams for treating neurological dis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-891092